tiprankstipranks
Trending News
More News >
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS

Compare Corvus Pharmaceuticals (CRVS) vs. Competitors

Compare
651 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Corvus Pharmaceuticals
$8.05
$601.19M
70.19%
3 Buy
0 Hold
0 Sell
Strong Buy
Altimmune
$4.24
$442.41M
-3.97
-36.81%
3 Buy
1 Hold
0 Sell
Strong Buy
Rigel
$37.48
$680.31M
6.08
116.02%
3 Buy
1 Hold
0 Sell
Strong Buy
Neurogene
$17.55
$271.85M
-3.96
-0.45%
5 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.64
$393.93M
-1.62
-64.35%
6 Buy
3 Hold
1 Sell
Moderate Buy
Astria Therapeutics
$12.47
$711.85M
-5.80
60.90%
0 Buy
3 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRVS
Corvus Pharmaceuticals
8.05
2.83
54.21%
ALT
Altimmune
4.24
-2.59
-37.92%
RIGL
Rigel
37.48
15.67
71.85%
NGNE
Neurogene
17.55
0.93
5.60%
RCKT
Rocket Pharmaceuticals
3.64
-6.52
-64.17%
ATXS
Astria Therapeutics
12.47
4.90
64.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts